589 related articles for article (PubMed ID: 37253877)
21. MHC class I-independent activation of virtual memory CD8 T cells induced by chemotherapeutic agent-treated cancer cells.
Wang X; Waschke BC; Woolaver RA; Chen SMY; Chen Z; Wang JH
Cell Mol Immunol; 2021 Mar; 18(3):723-734. PubMed ID: 32427883
[TBL] [Abstract][Full Text] [Related]
22. Resident memory T cells, critical components in tumor immunology.
Mami-Chouaib F; Blanc C; Corgnac S; Hans S; Malenica I; Granier C; Tihy I; Tartour E
J Immunother Cancer; 2018 Sep; 6(1):87. PubMed ID: 30180905
[TBL] [Abstract][Full Text] [Related]
23. Once upon a prime: DCs shape cancer immunity.
Zagorulya M; Spranger S
Trends Cancer; 2023 Feb; 9(2):172-184. PubMed ID: 36357313
[TBL] [Abstract][Full Text] [Related]
24. Microenvironment-driven metabolic adaptations guiding CD8
Park J; Hsueh PC; Li Z; Ho PC
Immunity; 2023 Jan; 56(1):32-42. PubMed ID: 36630916
[TBL] [Abstract][Full Text] [Related]
25. Tissue-Resident Memory T Cell: Ontogenetic Cellular Mechanism and Clinical Translation.
Xu H; Zhou R; Chen Z
Clin Exp Immunol; 2023 Dec; 214(3):249-259. PubMed ID: 37586053
[TBL] [Abstract][Full Text] [Related]
26. Functional Heterogeneity and Therapeutic Targeting of Tissue-Resident Memory T Cells.
van der Gracht ETI; Behr FM; Arens R
Cells; 2021 Jan; 10(1):. PubMed ID: 33467606
[TBL] [Abstract][Full Text] [Related]
27. Effector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune Response.
Reiser J; Banerjee A
J Immunol Res; 2016; 2016():8941260. PubMed ID: 27314056
[TBL] [Abstract][Full Text] [Related]
28. Rewiring Mitochondrial Metabolism for CD8
Li W; Zhang L
Front Immunol; 2020; 11():1834. PubMed ID: 32983095
[TBL] [Abstract][Full Text] [Related]
29. Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment.
Fu C; Jiang A
Front Immunol; 2018; 9():3059. PubMed ID: 30619378
[TBL] [Abstract][Full Text] [Related]
30. CXCR6 deficiency impairs cancer vaccine efficacy and CD8
Karaki S; Blanc C; Tran T; Galy-Fauroux I; Mougel A; Dransart E; Anson M; Tanchot C; Paolini L; Gruel N; Gibault L; Lepimpec-Barhes F; Fabre E; Benhamouda N; Badoual C; Damotte D; Donnadieu E; Kobold S; Mami-Chouaib F; Golub R; Johannes L; Tartour E
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33692218
[TBL] [Abstract][Full Text] [Related]
31. Heterogenous Populations of Tissue-Resident CD8
Milner JJ; Toma C; He Z; Kurd NS; Nguyen QP; McDonald B; Quezada L; Widjaja CE; Witherden DA; Crowl JT; Shaw LA; Yeo GW; Chang JT; Omilusik KD; Goldrath AW
Immunity; 2020 May; 52(5):808-824.e7. PubMed ID: 32433949
[TBL] [Abstract][Full Text] [Related]
32. Axes of heterogeneity in human tissue-resident memory T cells.
Szabo PA
Immunol Rev; 2023 Jul; 316(1):23-37. PubMed ID: 37211646
[TBL] [Abstract][Full Text] [Related]
33. Tumor-infiltrating lymphocytes in the immunotherapy era.
Paijens ST; Vledder A; de Bruyn M; Nijman HW
Cell Mol Immunol; 2021 Apr; 18(4):842-859. PubMed ID: 33139907
[TBL] [Abstract][Full Text] [Related]
34. Cancer stem-like cells evade CD8
Corgnac S; Damei I; Gros G; Caidi A; Terry S; Chouaib S; Deloger M; Mami-Chouaib F
J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35418483
[TBL] [Abstract][Full Text] [Related]
35. Big fish in small ponds: Narrow repertoires of stem-like tissue-resident T cells yield great power in anti-tumor immunity.
Smith KN
Immunity; 2022 Jun; 55(6):979-981. PubMed ID: 35705001
[TBL] [Abstract][Full Text] [Related]
36. Differential Expression of CD49a and CD49b Determines Localization and Function of Tumor-Infiltrating CD8
Melssen MM; Lindsay RS; Stasiak K; Rodriguez AB; Briegel AM; Cyranowski S; Rutkowski MR; Conaway MR; Melief CJM; van der Burg SH; Eyo U; Slingluff CL; Engelhard VH
Cancer Immunol Res; 2021 May; 9(5):583-597. PubMed ID: 33619119
[TBL] [Abstract][Full Text] [Related]
37. Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy.
Jiang W; He Y; He W; Wu G; Zhou X; Sheng Q; Zhong W; Lu Y; Ding Y; Lu Q; Ye F; Hua H
Front Immunol; 2020; 11():622509. PubMed ID: 33633741
[TBL] [Abstract][Full Text] [Related]
38. Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma.
Li H; van der Leun AM; Yofe I; Lubling Y; Gelbard-Solodkin D; van Akkooi ACJ; van den Braber M; Rozeman EA; Haanen JBAG; Blank CU; Horlings HM; David E; Baran Y; Bercovich A; Lifshitz A; Schumacher TN; Tanay A; Amit I
Cell; 2019 Feb; 176(4):775-789.e18. PubMed ID: 30595452
[TBL] [Abstract][Full Text] [Related]
39. Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy.
Luoma AM; Suo S; Wang Y; Gunasti L; Porter CBM; Nabilsi N; Tadros J; Ferretti AP; Liao S; Gurer C; Chen YH; Criscitiello S; Ricker CA; Dionne D; Rozenblatt-Rosen O; Uppaluri R; Haddad RI; Ashenberg O; Regev A; Van Allen EM; MacBeath G; Schoenfeld JD; Wucherpfennig KW
Cell; 2022 Aug; 185(16):2918-2935.e29. PubMed ID: 35803260
[TBL] [Abstract][Full Text] [Related]
40. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
